Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Beprost sodium tablets (kaina)

Improve the symptoms of ulcer, intermittent claudication, pain and cold caused by chronic arterial occlusive disease. More role
App download minus 10 yuan
Common name:
Beraprost Sodium Tablets
Product No.:
B14202037072
Approval No.:
Gyzz h20083589 (inquired by the State Drug Administration)
Jianke price:
¥99.00
Product specification:
forty μ g*10s twenty μ g*10s
Manufacturer:
Beijing Taide Pharmaceutical Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Beprost sodium tablets (kaina)
Main raw materials The main component of this product is beprost sodium. Its chemical name is: (SHI) - 2,3,3a,8b-tetrahydro-2-hydroxy-1 - (3-hydroxy-4-methyl-1-octene-6-alkynyl) - 1h-cyclopentano [b] benzofuran-5-butyrate sodium. See the description for the structural formula, molecular formula and molecular weight.
Main role Improve the symptoms of ulcer, intermittent claudication, pain and cold caused by chronic arterial occlusive disease.
Product specification forty μ g*10s
Usage and dosage Usually, adults take it orally after meals. Once 40 μ g. Three times a day.
manufacturing enterprise Beijing Taide Pharmaceutical Co., Ltd
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Beprost sodium tablets (kaina)

[common name] Beraprost Sodium Tablets

[specification and model] forty μ g*10s

[manufacturer] Beijing Taide Pharmaceutical Co., Ltd

[drug type] Western medicine

[approval No.] Gyzz h20083589

[validity period] 36 months

[functional indications] Improve the symptoms of ulcer, intermittent claudication, pain and cold caused by chronic arterial occlusive disease.

[usage and dosage] Usually, adults take it orally after meals. Once 40 μ g. Three times a day.

[adverse reactions] 1. Serious adverse reactions (1) Bleeding tendency [intracerebral hemorrhage (less than 0.1%), gastrointestinal hemorrhage (less than 0.1%), pulmonary hemorrhage (unknown incidence), fundus hemorrhage (less than 0.1%)]: close observation shall be carried out. In case of abnormality, drug administration shall be stopped and appropriate treatment shall be given. (2) Body gram (less than 0.1%): there are reports of shock, which should be closely observed. In case of lower blood pressure, faster heart rate, pale complexion, nausea and other symptoms, the administration should be stopped and appropriate treatment should be given. (3) Interstitial pneumonia (unknown incidence): there have been reports of interstitial pneumonia, which should be closely observed. In case of abnormalities, the administration should be stopped and appropriate treatment should be given. (4) Low liver function (unknown incidence): there have been reports of abnormal liver function such as jaundice and elevated got and GPT, which should be closely observed. In case of abnormalities, drug administration should be stopped and appropriate treatment should be given. (5) Angina pectoris (unknown incidence): there have been reports of angina pectoris. In case of abnormality, stop administration and give appropriate treatment. (6) Myocardial infarction (unknown incidence): there have been reports of myocardial infarction. In case of abnormality, stop administration and give appropriate treatment. 2. Other adverse reactions The following adverse reactions may occur, which should be closely observed and properly handled. (see instructions for table information)

[precautions] Please take medicine carefully for the following patients: 1. Patients who are using anticoagulants, antiplatelet drugs and thrombolytic agents. 2. Women in menstrual period. 3. Patients with bleeding tendency and its factors.

[taboo] Disabled when 1. Pregnant or potential pregnant women are forbidden to take this product (the safety of medication during pregnancy has not been determined). 2. Patients with bleeding (such as hemophilia, capillary fragility, upper gastrointestinal bleeding, urinary tract bleeding, hemoptysis, fundus hemorrhage, etc. taking this product may lead to increased bleeding).

[listing Permit Holder] Beijing Taide Pharmaceutical Co., Ltd

[packaging unit] box

[main ingredients] The main component of this product is beprost sodium. Its chemical name is: (SHI) - 2,3,3a,8b-tetrahydro-2-hydroxy-1 - (3-hydroxy-4-methyl-1-octene-6-alkynyl) - 1h-cyclopentano [b] benzofuran-5-butyrate sodium. See the description for the structural formula, molecular formula and molecular weight.

[character] The 20ug specification of this product is white to off white film coated tablets, with "bs20" engraved on one side, which is white after coating; 40ug is a light yellow film coated tablet with "bs40" engraved on one side, which is white after coating.

[applicable population] adult

[medication for pregnant and lactating women] 1. Pregnant or potential pregnant women are forbidden to take this product (the safety of medication during pregnancy has not been established). 2. Lactating women should avoid taking this product and stop lactation when necessary (animal experiments on rats show that this drug can be distributed in milk).

[medication for children] The safety of medication for children has not been established (no use experience).

[medication for elderly patients] Elderly patients should pay attention to the dosage (usually the physiological function of the elderly decreases).

[storage] Sealed and stored at room temperature.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Beprost sodium tablets (kaina)

    ¥99.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!